ANA Therapeutics: Niclosamide

Like almost all scientists, biologists and pharmaceutical researchers, Akash, Nadja and Andrew were not planning to work on COVID-19 treatments a few months ago.

They had just taken a big step with the FDA for their contraceptive treatment and were going full steam ahead in drug development. The company they founded, YourChoice Therapeutics, was poised for a big year. Then, the crisis hit. They realized their treatment could have an impact on COVID. The following weeks saw them pivoting their entire operation to try to help.

In this episode we discuss the science behind their treatment, the story of how they pivoted their company and the challenges they are facing.

Hosted on Breaker.